PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
12.21%
Revenue growth exceeding 1.5x VET's 5.64%. David Dodd would verify if faster growth reflects superior business model.
39.02%
Cost growth above 1.5x VET's 5.95%. Michael Burry would check for structural cost disadvantages.
-11.05%
Gross profit decline while VET shows 5.57% growth. Joel Greenblatt would examine competitive position.
-20.72%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.17%
Other expenses reduction while VET shows 0.00% growth. Joel Greenblatt would examine efficiency.
-5.90%
Operating expenses reduction while VET shows 21.67% growth. Joel Greenblatt would examine advantage.
18.76%
Total costs growth 1.1-1.25x VET's 16.21%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
6.36%
D&A growth above 1.5x VET's 4.13%. Michael Burry would check for excessive investment.
-5.71%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-3.97%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-11.02%
Both companies show declining income. Martin Whitman would check industry conditions.
-20.70%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-292.33%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-56.11%
Both companies show declining income. Martin Whitman would check industry conditions.
-60.89%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-245.23%
Both companies reducing tax expense. Martin Whitman would check patterns.
-18.12%
Both companies show declining income. Martin Whitman would check industry conditions.
-27.03%
Both companies show margin pressure. Martin Whitman would check industry conditions.
13.67%
EPS growth while VET declines. John Neff would investigate advantages.
11.51%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-5.18%
Both companies reducing share counts. Martin Whitman would check patterns.
-3.90%
Diluted share reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.